How to enhance productivity with an integrated compliance-ready software platform for analyses requiring chromatographic and mass spectrometric analysis

The right CDS (Chromatography Data System) ensures data quality and manages all the necessary processes along the analytical workflow from instrument control, to raw data storage and processing, right through to generating reports of the final results, allowing pharma and biopharma companies and contract research organizations to leverage their MS systems throughout various stages of research and product development, taking advantage of compliance-readiness when needed.

In this webinar, Dr. Dan Bach Kristensen, principal scientist at Danish clinical-stage antibody oncology-focused company, Symphogen, shares examples of how to boost productivity by using the right LC-MS software to streamline analytical workflows and enable the use of MS as a routine detector.

Key learning objectives:

• How to develop platform workflows supported by the right CDS for simplified characterization and quality monitoring of complex therapeutic proteins
• How to translate biopharmaceutical characterization methods into transferable, routine, compliance-ready solutions
• How to gain understanding and alignment with the analytical data generation and handling requirements for complex monoclonal antibodies

Who should attend?

Traditional pharmaceutical and biopharmaceutical companies (although any laboratory requiring compliance-ready MS data acquisition and processing capabilities will find this informative), with the main targets being: lab managers and directors, IT managers, C-Suite, QA managers, analytical scientists in existing late-stage development, QA/QC and contract laboratories running analyses requiring chromatography data system software, with focus on transferring LC-MS methods further into development where compliance-ready streamlined software solutions are needed.

Presenter: Dr. Dan Bach Kristensen (Principal Scientist, Symphogen—a Servier Company)

Dan Bach Kristensen holds a Ph.D. in biology and BSc. degree in chemistry. Dan is specialized in protein chemistry and mass spectrometry, which he initially applied in the field of proteome research in Japan and later in Denmark. For the past 15 years, Dan has been working with analytical development in the biopharmaceutical industry, on projects ranging from early discovery through to product registration. Clinical indications include bleeding disorders, neutropenia, autoimmune diseases, and oncology. Dan currently works as a principal scientist at Symphogen, which is specialized in the development of antibodies and antibody mixtures for the treatment of cancer.

Moderator: Finn Price (Editorial Team, SelectScience)

Fionnbhar Price is a member of the SelectScience Editorial Team, who plays a core role in sourcing and publishing content for the site, with a particular focus on the field of applied chemistry. He has an MChem in Chemistry from Cardiff University, UK, and undertook a year in research characterizing bacterial protein.